<--- Back to Details
First PageDocument Content
Medicine / Aging / Gerontology / Progeria / Chemistry / Farnesyltransferase inhibitor / Lonafarnib / Paa / Hayley Okines / Health / Genodermatoses / Rare diseases
Date: 2013-10-20 19:26:17
Medicine
Aging
Gerontology
Progeria
Chemistry
Farnesyltransferase inhibitor
Lonafarnib
Paa
Hayley Okines
Health
Genodermatoses
Rare diseases

Contact: Frannie Marmorstein[removed]removed] FOR IMMEDIATE RELEASE

Add to Reading List

Source URL: www.progeriaresearch.org

Download Document from Source Website

File Size: 313,87 KB

Share Document on Facebook

Similar Documents

Chemistry / Rare diseases / Aging / Gerontology / Progeria / Lonafarnib / Sirolimus / Clinical trial / Health / Medicine / Genodermatoses

Timeline Highlights through July 2014: Our History, Our Future… March 1999: The Progeria Research Foundation (PRF) is incorporated as a Massachusetts non-profit organization. June 9, 1999: the Board of Director

DocID: 1aFeL - View Document

Rare diseases / Aging / Gerontology / Progeria / Farnesyltransferase inhibitor / Progerin / LMNA / Lonafarnib / Clinical trial / Health / Genodermatoses / Medicine

news WWW.PROGERIARESEARCH.ORG • SEPTEMBER, 2012 S P

DocID: r7kL - View Document

Rare diseases / Aging / Gerontology / Progeria / Farnesyltransferase inhibitor / Progerin / LMNA / Lonafarnib / Clinical trial / Health / Genodermatoses / Medicine

news WWW.PROGERIARESEARCH.ORG • SEPTEMBER, 2012 S P

DocID: r6Ap - View Document

Rare diseases / Aging / Gerontology / Progeria / Farnesyltransferase inhibitor / Progerin / LMNA / Lonafarnib / Clinical trial / Health / Genodermatoses / Medicine

news WWW.PROGERIARESEARCH.ORG • SEPTEMBER, 2012 S P

DocID: r3Ff - View Document

Medicine / Aging / Gerontology / Progeria / Chemistry / Farnesyltransferase inhibitor / Lonafarnib / Paa / Hayley Okines / Health / Genodermatoses / Rare diseases

Contact: Frannie Marmorstein[removed]removed] FOR IMMEDIATE RELEASE

DocID: qN68 - View Document